期刊文献+

糖尿病患者糖化血红蛋白和Lp(a)水平关系研究 被引量:1

The Research of Relationship between Glycosylated Hemodlobin and Lipoprotein(a) Levels in Diabetic Patients
下载PDF
导出
摘要 目的:探讨Ⅱ型糖尿病血糖控制欠佳时,糖化血红蛋白(GHb)与Lp(a)浓度的关系。方法:采用免疫浊度法对20例GHb(HbA1c)高于正常的Ⅱ型糖尿病患者和20例正常对照组的血浆Lp(a)进行测定。结果:GHb升高组和正常对照组的Lp(a)分布均呈偏态;GHb升高组Lp(a)显著高于对照组(p<0.01);根据HbA1c水平,将GHb升高组分成三组,三组间Lp(a)的水平差异无统计学意义(p>0.05);相关分析发现Lp(a)与HbA1c无相关性(p>0.05)。结论:Ⅱ型糖尿病GHb的升高对Lp(a)水平无影响。 Objective: To investigate the relationship between glycosylated hemodlobin ( GHb ) and lipoprotein(a ) concentrations of poorly glycemic control in type 2 diabetic patients. Method: The plasma Lp (a) was analysed in highly GHb( HbAlc) levels in type 2 diabetic patients and 20 control subjects. Result: The distribution of plasma Lp( a) was skewed in highly glycated hemoglobin group and control subjects. The plasma Lp( a) levels in highly glycated hemoglobin group were Significantly higher than those in control subjects (p 〈0.01 ). Type 2 diabetic patients were divided into three groups based on GHb( HbAlc) levels.There were no significant differences in Lp ( a ) levels among three groups of diabetic patients ( p 〉 0.05 ). Lp ( a) levels were not correlated to HbAIe (p 〉 0. 051. Conclusion: Lp(a) levels were not influence in GHb rise in type 2 diabetic patients.
出处 《河北医学》 CAS 2006年第4期298-300,共3页 Hebei Medicine
关键词 糖化血红蛋白 脂蛋白(a) 糖尿病 血糖 Glycosylated hemodlobin Lipoprotein ( a) Diabetes Glycemic
  • 相关文献

参考文献9

  • 1Bierman EL.George lyman Duff Memorial lecture:A therogensis in diabetes[J].Arterioscler Thromb,1992,12:647-656.
  • 2Harmel AP,Ryan D,Thompsn R.Glycohemoglobin assessment program:glycated hemoglobin and epidemiologic variables in patients with type 2 diabetes[J].Endocr Pract,2002,8(3):184-190.
  • 3Koschinsky ML,Marcovina SM.Structure-function relationships in apolipoprotein(a):insights into lipoprotein (a) assembly and pathogenicity[J].Curr Opin Lipidol,2004,15(2):167-174.
  • 4赵仲农,汪俊军,庄一义,季大玺.糖尿病肾病患者脂蛋白(a)的异常[J].江苏医药,1995,21(4):258-259. 被引量:5
  • 5Ramirez LC,Arauz-Pacheco C,Lackner C,et al.Lipoprotein(a) levels in diabetes mellitus:relationship to metabolic control[J].Ann Intern Med,1992,117(1):42-47.
  • 6Alsaeid M,Moussa MA,Haider MZ,Refai TM,et al.Angiotensin-converting enzyme gene polymorphism and lipid profiles in Kuwaiti children with type Ⅰ diabetes[J].Pediatr Diabetes,2004,5(2):87-94.
  • 7Haffiner SM,Morales PA,Stern MP,et al.Lp(a) concentrations in NIDDM[J].Diabetes,1992,41(10):1267-1272.
  • 8Rifai N,Ma J,Sacks FM,et al.Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men:The Physicians' Health Study[J].Clin Chem,2004,50(8):1364-1371.
  • 9Goldberg AC.A meta-analysis of randomized controlled studies on the effects of extended-release niacin in women[J].Am Cardiol,2004,94(1):121-124.

共引文献4

同被引文献7

  • 1罗海芸,蒲里津,光雪峰,白文伟,张戈,章克信.血清糖化血红蛋白及脂蛋白-(a)水平变化与糖尿病并发冠心病的关系[J].微循环学杂志,2007,17(3):39-41. 被引量:3
  • 2Haffner SM,Lehto S, ROnnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction[J]. N Engl J Med, 1998,339 (4) :229-234.
  • 3Bierman EL. George Lyman Duff Memorial Lecture. Athero- genesis in diabetes [ J ]. Arterioscler Thromb, 1992, 12 ( 6 ) :647-656.
  • 4O'Sullivan CJ, Hynes N, Mahendran B,et al. Haemoglo- bin Alc (HbAIC) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predic- tor of adverse outcome? [J]. Eur J Vase Endovasc Surg, 2006,32(2) : 188-197.
  • 5Dilley J, Ganesan A, Deepa R, et al. Association of A1C with cardiovascular disease and metabolic syndrome in A- sian Indians with normal glucose tolerance[J]. Diabetes Care,2007,30(6) : 1527-1532.
  • 6许磊,李红.糖化血红蛋白升高与脂蛋白(a)相关性研究[J].中外健康文摘,2009,6(19):16-17.
  • 7Mora S,Kamstrup PR, Rifai N, et al. Lipoprotein(a) and risk of type 2 diabetes[J]. Clin Chem,2010,56(8) :1252- 1260.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部